• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Clinical laboratory characteristics in patients with suspected COVID-19: one single institution experience

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Sep 18.
doi: 10.1002/jmv.26527. Online ahead of print.
Clinical laboratory characteristics in patients with suspected COVID-19: one single institution experience


Fei Fei[SUP] 1 [/SUP], John A Smith[SUP] 1 [/SUP], Liyun Cao[SUP] 1 [/SUP]



Affiliations

Abstract

Objectives: Since December 2019, the outbreak of coronavirus disease 2019 (COVID-19) has become a worldwide pandemic. The aim of the study is to investigate the demographic, clinical and laboratory characteristics in suspected COVID-19 patients in our institution.
Methods: In this retrospective study, we investigated suspected COVID-19 patients admitted to the University of Alabama at Birmingham with a request for IL-6 send-out test, from March 28 to June 27, 2020. Patients' demographic, clinical and laboratory characteristics were collected by chart review.
Results: Fifty patients suspected with COVID-19 were included in our study, of whom 24 patients were positive with severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) infection and 26 were negative. During the observation period, 30 patients were discharged, 17 died during hospitalization, and three remained in hospital. Compared to non-COVID-19 patients, COVID-19 patients had an older age, more comorbidities, and elevated levels of inflammation markers such as ESR, CRP, serum ferritin and LDH. However, there was no significant difference in laboratory data between survivors and non-survivors in COVID-19 patients in our study.
Conclusion: This study indicated that potential risk factors of older age, multiple comorbidities and high levels of ESR, CRP, serum ferritin and LDH could help clinician to identify potential COVID-19 patients. However, this data needs to be further validated in a larger population. This article is protected by copyright. All rights reserved.

Keywords: Coronavirus disease 2019 (COVID-19); Infection; Inflammation; Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2).
 
Back
Top Bottom